94
Participants
Start Date
June 20, 2011
Primary Completion Date
November 10, 2017
Study Completion Date
March 17, 2026
Carboplatin
Given IV
Laboratory Biomarker Analysis
Correlative studies
Paclitaxel
Given IV
Pharmacological Study
Correlative studies
Veliparib
Given PO
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center-Weiler Hospital, The Bronx
Montefiore Medical Center - Moses Campus, The Bronx
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Emory University Hospital/Winship Cancer Institute, Atlanta
Moffitt Cancer Center, Tampa
Case Western Reserve University, Cleveland
Wayne State University/Karmanos Cancer Institute, Detroit
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
M D Anderson Cancer Center, Houston
City of Hope Comprehensive Cancer Center, Duarte
City of Hope South Pasadena, South Pasadena
University of California Davis Comprehensive Cancer Center, Sacramento
Dana-Farber Cancer Institute, Boston
Rutgers Cancer Institute of New Jersey, New Brunswick
Penn State Milton S Hershey Medical Center, Hershey
Collaborators (1)
Abbott
INDUSTRY
National Cancer Institute (NCI)
NIH